Phase II trial of neoadjuvant S-1 and concurrent radiotherapy for borderline resectable pancreatic cancer (JASPAC05)

被引：0

作者：

Ohno, Izumi ^{[1
]}

Takahashi, Shinichiro ^{[2
]}

Kobayashi, Tatsushi ^{[3
]}

Akimoto, Tetsuo ^{[4
]}

Toyama, Hirochika ^{[5
]}

Shimizu, Yasuhiro ^{[6
]}

Morinaga, Soichiro ^{[7
]}

Nakamori, Shoji ^{[8
]}

Hishinuma, Shoichi ^{[9
]}

Takakura, Norihisa ^{[10
]}

Takayama, Wataru ^{[11
]}

Hirano, Satoshi ^{[12
]}

Otsubo, Takehito ^{[13
]}

Ikeda, Masafumi ^{[1
]}

Uesaka, Katsuhiko ^{[14
]}

机构：

[1] Natl Canc Ctr East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan

[2] Natl Canc Ctr Hosp East, Dept Hepatobiliary Pancreat Surg, Kashiwa, Chiba, Japan

[3] Natl Canc Ctr Hosp East, Dept Diagnost Radiol, Kashiwa, Chiba, Japan

[4] Natl Canc Ctr Hosp East, Div Radiat Oncol & Particle Therapy, Kashiwa, Chiba, Japan

[5] Kobe Univ, Grad Sch Med, Dept Hepatobiliary Pancreat Surg, Kobe, Hyogo, Japan

[6] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Nagoya, Aichi, Japan

[7] Kanagawa Canc Ctr, Dept Surg Gastroenterol, Yokohama, Kanagawa, Japan

[8] Natl Hosp Org Osaka Natl Hosp, Dept Hepatobiliary Pancreat Surg, Osaka, Japan

[9] Tochigi Canc Ctr, Dept Hepatobiliary Pancreat Surg, Utsunomiya, Tochigi, Japan

[10] Fukuyama City Hosp, Dept Surg, Fukuyama, Hiroshima, Japan

[11] Chiba Canc Ctr, Dept Hepatobiliary Pancreat Surg, Chiba, Japan

[12] Hokkaido Univ, Fac Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido, Japan

[13] St Marianna Univ, Sch Med Hosp, Dept Gastroenterol Surg, Kawasaki, Kanagawa, Japan

[14] Shizuoka Canc Ctr, Dept Hepatobiliary Pancreat Surg, Nagaizumi, Shizuoka, Japan

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O3 - 11 -

引用

页数：2

共 50 条

[41] Relationship between surgical R0 resectability and findings of peripancreatic vascular invasion on CT imaging after neoadjuvant S-1 and concurrent radiotherapy in patients with borderline resectable pancreatic cancer
Sho Yasuta
Tatsushi Kobayashi
Hidetoshi Aizawa
Shinichiro Takahashi
Masafumi Ikeda
Masaru Konishi
Motohiro Kojima
Hirofumi Kuno
Katsuhiko Uesaka
Soichiro Morinaga
Atsushi Miyamoto
Hirochika Toyama
Norihisa Takakura
Keishi Sugimachi
Wataru Takayama
BMC Cancer, 20
[42] A phase II trial of oral fluoropyrimidine anticancer agent (S-1) with concurrent external-beam radiotherapy for locally advanced pancreatic cancer
Shinchi, H.
Maemura, K.
Mataki, Y.
Kurahara, H.
Natsugoe, S.
Takao, S.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[43] Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial
Fuyuhiko Motoi
Kazuyuki Ishida
Fumiyoshi Fujishima
Shigeru Ottomo
Masaya Oikawa
Takaho Okada
Hiromune Shimamura
Shinichi Takemura
Fuminori Ono
Masanori Akada
Kei Nakagawa
Yu Katayose
Shinichi Egawa
Michiaki Unno
Annals of Surgical Oncology, 2013, 20 : 3794 - 3801
[44] A phase I study of neoadjuvant chemotherapy with gemcitabine plus oral S-1 for resectable pancreatic cancer
Tajima, Hidehiro
Kitagawa, Hirohisa
Tsukada, Tomoya
Nakanuma, Shinich
Okamoto, Koichi
Sakai, Seisho
Makino, Isamu
Furukawa, Hiroyuki
Nakamura, Keishi
Hayashi, Hironori
Oyama, Katsunobu
Inokuchi, Masafumi
Nakagawara, Hisatoshi
Miyashita, Tomoharu
Fujita, Hideto
Itoh, Hiroshi
Takamura, Hiroyuki
Ninomiya, Itasu
Fushida, Sachio
Fujimura, Takashi
Ohta, Tetsuo
MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (04) : 768 - 772
[45] Neoadjuvant Chemotherapy with Gemcitabine and S-1 for Resectable and Borderline Pancreatic Ductal Adenocarcinoma: Results from a Prospective Multi-institutional Phase 2 Trial
Motoi, Fuyuhiko
Ishida, Kazuyuki
Fujishima, Fumiyoshi
Ottomo, Shigeru
Oikawa, Masaya
Okada, Takaho
Shimamura, Hiromune
Takemura, Shinichi
Ono, Fuminori
Akada, Masanori
Nakagawa, Kei
Katayose, Yu
Egawa, Shinichi
Unno, Michiaki
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (12) : 3794 - 3801
[46] Relationship between surgical R0 resectability and findings of peripancreatic vascular invasion on CT imaging after neoadjuvant S-1 and concurrent radiotherapy in patients with borderline resectable pancreatic cancer
Yasuta, Sho
Kobayashi, Tatsushi
Aizawa, Hidetoshi
Takahashi, Shinichiro
Ikeda, Masafumi
Konishi, Masaru
Kojima, Motohiro
Kuno, Hirofumi
Uesaka, Katsuhiko
Morinaga, Soichiro
Miyamoto, Atsushi
Toyama, Hirochika
Takakura, Norihisa
Sugimachi, Keishi
Takayama, Wataru
BMC CANCER, 2020, 20 (01)
[47] A Phase I Trial of S-1 with Concurrent Radiotherapy in Elderly Patients with Esophageal Cancer
Ji, Y.
Du, X.
Qiu, G.
Mao, C.
Sun, X.
Zheng, Y.
Xu, Y.
Cheng, J.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S168 - S168
[48] PHASE II STUDY OF PREOPERATIVE S-1, IRINOTECAN PLUS OXIARIPLATINE COMBINATION THERAPY (S-IROX) FOR BORDERLINE RESECTABLE PANCREATIC CANCER
Maruki, Yuta
Nara, Satoshi
Kondo, Shunsuke
Ohba, Akihiro
Mizui, Takahiro
Takamoto, Takeshi
Nagashio, Yoshikuni
Ban, Daisuke
Hijioka, Susumu
Morizane, Chigusa
Ueno, Hideki
Sugawara, Shunsuke
Sone, Miyuki
Hiraoka, Nobuyoshi
Okusaka, Takuji
Esaki, Minoru
Shimada, Kazuaki
GASTROENTEROLOGY, 2022, 162 (07) : S1069 - S1070
[49] A phase II study of S-1 with concurrent radiotherapy in elderly patients with esophageal cancer
Ji, Yongling
Du, Xianghui
Tian, Ye
Sheng, Liming
Cheng, Lei
Chen, Ying
Qiu, Guoqing
Zhou, Xia
Bao, Wuan
Zhang, Danhong
Chen, Ming
ONCOTARGET, 2017, 8 (47) : 83022 - 83029
[50] A phase II study of S-1 with concurrent radiotherapy for elderly esophageal cancer patients
Song, T.
Lv, S.
ANNALS OF ONCOLOGY, 2016, 27

← 1 2 3 4 5 →